Millennium Management LLC Has $1.42 Million Stock Holdings in Seer, Inc. (NASDAQ:SEER)

Millennium Management LLC grew its position in shares of Seer, Inc. (NASDAQ:SEER) by 9.1% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 615,812 shares of the company’s stock after purchasing an additional 51,150 shares during the quarter. Millennium Management LLC owned approximately 1.04% of Seer worth $1,423,000 as of its most recent SEC filing.

A number of other hedge funds have also recently made changes to their positions in the company. Dimensional Fund Advisors LP lifted its position in shares of Seer by 4.1% in the 4th quarter. Dimensional Fund Advisors LP now owns 127,711 shares of the company’s stock worth $295,000 after purchasing an additional 5,000 shares during the period. Corient Private Wealth LLC lifted its holdings in Seer by 66.0% in the fourth quarter. Corient Private Wealth LLC now owns 33,200 shares of the company’s stock valued at $77,000 after buying an additional 13,200 shares during the period. Y Intercept Hong Kong Ltd acquired a new position in Seer in the fourth quarter valued at $36,000. Bank of America Corp DE lifted its holdings in Seer by 18.3% in the fourth quarter. Bank of America Corp DE now owns 151,337 shares of the company’s stock valued at $350,000 after buying an additional 23,411 shares during the period. Finally, Schonfeld Strategic Advisors LLC acquired a new position in Seer in the fourth quarter valued at $103,000. 75.20% of the stock is owned by institutional investors and hedge funds.

Seer Stock Performance

Shares of NASDAQ SEER opened at $2.14 on Wednesday. The firm’s 50-day moving average price is $1.96 and its 200-day moving average price is $2.16. Seer, Inc. has a 1-year low of $1.56 and a 1-year high of $2.63. The firm has a market capitalization of $125.98 million, a P/E ratio of -1.65 and a beta of 1.58.

Seer (NASDAQ:SEER) last posted its quarterly earnings data on Tuesday, May 13th. The company reported ($0.34) EPS for the quarter, beating the consensus estimate of ($0.37) by $0.03. Seer had a negative net margin of 565.83% and a negative return on equity of 21.96%. The firm had revenue of $4.21 million during the quarter, compared to analyst estimates of $3.25 million. Equities research analysts forecast that Seer, Inc. will post -1.42 EPS for the current year.

Seer Profile

Seer, Inc, a life sciences company, engages in developing and commercializing products to decode the biology of the proteome. It develops Proteograph Product Suite, an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation, and software to perform proteomic analysis to provide a solution that can be incorporated by nearly any lab for research use only.